News By Tag
* Biopharmaceuticals Market
* Recombinant proteins market
* Monoclonal Antibodies Market
* More Tags...
News By Place
IMARC Group Releases the Most Comprehensive Report on the Global Biopharmaceutical Market
Driven by their target oriented nature that enables them to attack only the diseased cells without affecting the healthy ones, biopharmaceuticals today represent one of the fastest growing segments of the pharmaceutical industry.
Research firm IMARC Group expects this market to grow at a CAGR of around 8.2% during 2011-2017, according to its latest report titled “Global Biopharmaceutical Market Report & Forecast (2012-2017)”. The report which has done a comprehensive analysis of all major developed and emerging biopharmaceutical markets expects biologicals to account for nearly 15% of the global pharmaceutical market by 2017. According to an analyst at IMARC Group, “a major advantage of biopharmaceuticals is that they can be tailored as per the individual needs of a patient. This enables biopharmaceuticals to be target oriented and highly specific in nature. The target oriented nature of biopharmaceuticals enables them to attack only the diseased cells without affecting the healthy ones. This results in lower side effects and a very high efficacy”.
IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2012-2017)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market trends, geographical structure, therapeutic structure, competitive structure and the outlook of the global biopharmaceutical market till 2017. This report will serve as an excellent guide for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the global biopharmaceutical market in any form.
What We Have Achieved in this Report?
Deep Qualitative Understanding of Various Factors Driving and Restraining the Global Biopharmaceutical Market
Key Aspects Analyzed:
• Driving Factors
• Restraining Factors
• Market Opportunities
Comprehensive Situation Analysis of the Global Biopharmaceutical Market and its Dynamics
North America: United States and Canada
Latin America: Mexico, Brazil and Argentina
Europe: Germany, France, Italy, Spain, United Kingdom, Russia and Turkey
Asia Pacific: Japan, China, Australia, South Korea, India and Indonesia
Classes Covered for Each Country: Erythropoietins, Insulin, Interferons, Growth Hormones, Immunoglobulins, Colony Stimulating Factors, Recombinant Blood Factors, Recombinant Enzymes, Growth Factors, Interleukins, Monoclonal Antibodies and Purified Proteins
Focus of the Analysis for Each Country:
• Total Market Performance (2005 - 2011)
• Performance of Various Classes (2005 - 2011)
• Performance of Top Players (2005 - 2011)
• Market Forecast (2012 - 2017)
Key Questions Answered in this Report:
• What are the key advantages/ disadvantages of biopharmaceuticals over small molecule drugs in terms of efficacy, safety, price, approval times, market growth, etc.?
• What are the key opportunities and threats faced by the biopharmaceutical industry?
• What has been the historical and current performance of the global biopharmaceutical market and how is it expected to perform in the coming years?
• Which are the world’s largest biopharmaceutical markets?
• Which are the world’s fastest growing biopharmaceutical markets?
• What is the structure and composition of various biopharmaceutical markets across the globe?
• Which are the world’s largest biopharmaceutical segments?
• Which are the world’s fastest growing biopharmaceutical segments?
• Who are the world’s largest biopharmaceutical companies and how have they performed in recent years?
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia
IMARC Group North America
IMARC Group Europe, Middle East & Africa